ODC provides the ecosystem access that pharmaceutical sponsors need to recruit faster, retain more patients, and execute studies efficiently across key Latin American countries.
A purpose-built infrastructure connecting sponsors, physicians, research centers, and patients across the region.
Patient Identification
ODC works with a referral infrastructure that supports patient identification and trial awareness through treating physicians — reflecting how patients in the region typically learn about clinical trial opportunities.
validated physicians across Latin America
Infrastructure & Ecosystem
Research sites are prepared and trained for trial participation, with long-standing investigator relationships enabling faster activation timelines and more reliable study startup. ODC maintains relationships with medical societies, patient advocacy organizations, and regulatory stakeholders.
research sites across Brazil, Argentina, and Chile
Digital & In-Person Outreach
Our omnichannel recruitment approach integrates in-person visits, digital outreach and campaigns, physician referrals, and site-level engagement into a single, coordinated strategy, ensuring patients are reached at every step of their journey.
Strategic Partnerships
ODC maintains long-standing relationships with medical societies, patient advocacy organizations, and regulatory stakeholders across Latin America — enabling streamlined site activation, faster regulatory approvals, and deeper community trust.
End-to-end patient support
Dedicated patient support programs guide participants through the study journey — including scheduling coordination, education, and logistical assistance — contributing to strong retention and consistent engagement throughout the trial lifecycle.
420
260
80
65
47
LATAM shows
significantly lower trial
density — meaning less
competition for eligible
patients.
| Region | Trial Saturation | Naïve Access |
|---|---|---|
| United States |
Very high
|
Lower
|
| Western Europe |
High
|
Moderate
|
| Latin America |
Lower
|
Higher
|
Earlier-stage patient
populations across
multiple therapeutic
areas.
37%
Sites fail to enroll a single patient
<1
Avg. patients per site/month
2-3x
Faster enrollment in LATAM sites
Higher per-site
enrollment means fewer
sites needed and faster
timelines.
United States
$1.00
Latin America avg.
~$0.56
~44% lower operating
costs in LATAM vs. the
United States.
Regulatory modernization and optimized approval pathways
Argentina
Experienced research centers and structured ethical review processes
Chile
Stable regulatory oversight and strong clinical research infrastructure
Increasing ICH alignment
enables streamlined
multi-regional
submissions.
We enable access to clinical success in LATAM
No results found.
Explore more clinical trial insights and case studies from across Latin America.